Labcyte to Support GP-write Project Harness Knowledge from Human Genome Project

Written by Bioscribe on July 19, 2018

  • 5Shares

Labcyte is helping an international network of scientists in their quest to harness the blueprints provided by the Human Genome Project (HGP-read), to rewrite the capabilities of modern genomics.

As part of an agreement with the Center for Excellence in Engineering Biology (CEEB), an independent nonprofit that is managing initial planning and coordination of efforts for the Genome Project-write (GP-write), Labcyte will provide preferred pricing and in-kind support to researchers at qualified laboratories that are affiliated with and contributing to the project. Additionally, Labcyte will provide selected researchers with early access to certain new products we develop.

GP-write is an open, international scientific research project led by a multi-disciplinary group of scientific leaders who are aiming to develop new genomics analysis, design, synthesis, assembly and testing technologies, including recoding DNA and creating “ultra-safe” cell lines that resist natural viruses. GP-write is also developing an ethical framework for genome-scale engineering and transformative medical applications.

The group expects to oversee a reduction in the costs of engineering and testing of large genomes in cell lines by more than 1,000-fold within 10 years. Thus far, nearly 200 scientists affiliated with more than 100 organizations from 15 countries are involved in the project.

As reported in an earlier post, Labcyte is one of the founding members of the GP-write Industry Advisory Board, which is charged with developing complete workflow solutions for laboratories participating in the project.

“Synthetic biology is another rapidly growing application of our touchless acoustic liquid handling systems which are broadly used in workflows ranging from drug discovery to personalized medicine to diagnostics, all of which achieve lower costs, faster assembly times and less reagent consumption,” said Labcyte Chief Executive Officer, Mark Fischer-Colbrie.

“We are delighted to partner with GP-write and to support researchers working in this field. We look forward to seeing how we can innovate and push discoveries ahead faster together.”

“Labcyte is an ideal partner for this important and far-reaching project, which aims to facilitate the use of biological engineering to address many global challenges facing humanity,” said Nancy J. Kelley, organizer and lead executive of the CEEB. “Labcyte’s revolutionary technology is uniquely suited to accelerate the work of the interdisciplinary research teams working around the globe that have engaged with GP-write.”

Add Comment

LOGIN to write a comment